Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Giving Standardized Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy

NCT06005610 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT06005610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Giving Standardized Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Terminated
Start date
January 4, 2024
Completion date
August 21, 2025
Enrollment
93 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hiv i infection